NHC Reports Director/Officer Changes and Compensatory Arrangements
Ticker: NHC · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1047335
Sentiment: neutral
Topics: management-change, compensation, regulation-fd
TL;DR
NHC filed an 8-K detailing director/officer changes and compensation updates.
AI Summary
National Healthcare Corporation (NHC) filed an 8-K on November 12, 2025, reporting events that occurred on November 6, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements with exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and executive compensation structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensation adjustments, can indicate internal shifts that may affect future performance or strategy.
Key Numbers
- 20251112 — Filing Date (Date the 8-K was officially filed with the SEC.)
- 20251106 — Event Date (Earliest date of events reported in the filing.)
Key Players & Entities
- NATIONAL HEALTHCARE CORPORATION (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 100 Vine Street Murfreesboro, Tennessee 37130 (address) — Principal Executive Offices
FAQ
What specific director or officer positions were affected by the reported departures or appointments?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify the names or exact roles in the provided text.
Are there any details regarding the compensatory arrangements for the officers mentioned?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specific details of these arrangements are not included in the provided excerpt.
What is the significance of the Regulation FD Disclosure mentioned?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, suggesting that the company may have made such disclosures or is adhering to these rules.
What type of financial statements and exhibits are included with this 8-K filing?
The filing states "Financial Statements and Exhibits" are included, but the specific nature or content of these documents is not detailed in the provided text.
What is the primary business of National Healthcare Corporation based on its SIC code?
National Healthcare Corporation's Standard Industrial Classification (SIC) code is 8051, which corresponds to SERVICES-SKILLED NURSING CARE FACILITIES.
Filing Stats: 1,214 words · 5 min read · ~4 pages · Grade level 10.5 · Accepted 2025-11-12 16:17:17
Key Financial Figures
- $0.1 — nge on which registered Common Stock , $0.1 par value NHC NYSE American Indicat
- $700 million — for the State of Tennessee, managing a $700 million budget and over 4,300 employees, and le
- $1.1 billion — esident of West Tennessee Healthcare, a $1.1 billion not-for-profit health system, where she
Filing Documents
- nhc20251112_8k.htm (8-K) — 30KB
- ex_887680.htm (EX-99.1) — 6KB
- 0001437749-25-034451.txt ( ) — 168KB
- nhc-20251106.xsd (EX-101.SCH) — 3KB
- nhc-20251106_def.xml (EX-101.DEF) — 11KB
- nhc-20251106_lab.xml (EX-101.LAB) — 15KB
- nhc-20251106_pre.xml (EX-101.PRE) — 11KB
- nhc20251112_8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On November 12, 2025, NHC issued a press release announcing the election of a new director described in Item 5.02 above. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-k. Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Number Exhibit 99.1 Press Release Dated November 12, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 12, 2025 NATIONAL HEALTHCARE CORPORATION By: /s/Stephen F. Flatt Name: Stephen F. Flatt Title: CEO